Quotes 5-day view Delayed Nyse
02/01/2023
02/02/2023
02/03/2023
02/06/2023
02/07/2023
Date
139.27(c)
144.38(c)
141.75(c)
137.9(c)
139.5
Last
1 238 224
933 579
756 033
528 362
569 872
Volume
+1.27%
+3.67%
-1.82%
-2.72%
+1.16%
Change
Estimated financial data (e) (USD)
Sales 2022
4 594 M
-
-
Net income 2022
583 M
-
-
Net Debt 2022
3 708 M
-
-
P/E ratio 2022
30,1x
Yield 2022
0,20%
Sales 2023
3 116 M
-
-
Net income 2023
484 M
-
-
Net Debt 2023
1 056 M
-
-
P/E ratio 2023
36,5x
Yield 2023
0,20%
Capitalization
17 621 M
17 621 M
-
EV / Sales 2022
4,64x
EV / Sales 2023
5,99x
Nbr of Employees
16 700
Free-Float
99,8%
PerkinElmer, Inc. specializes in designing, manufacturing, and marketing measurement devices and analytical instruments for the healthcare, environmental, scientific research, industry and food sectors. Net sales break down by family of products as follows :
- medical diagnosis equipments (57.9%);
- analytical tools and instruments (42.1%): biological molecular research tools, thermal analysis software, chemical...
Ratings of PerkinElmer, Inc.
All news about PERKINELMER, INC.
News in other languages on PERKINELMER, INC.
Analyst Recommendations on PERKINELMER, INC.
ETFs positioned on PERKINELMER, INC. ETFs and Trackers with Trackinsight
Moderna names PerkinElmer exec as new CFO
Duration :
Auto.
2 months
3 months
6 months
9 months
1 year
2 years
5 years
10 years
Max.
Period :
Day
Week
Technical analysis trends PERKINELMER, INC.
Short Term Mid-Term Long Term Trends Neutral Neutral Bearish
Income Statement Evolution
Please enable JavaScript in your browser's settings to use dynamic charts.
Mean consensus
OUTPERFORM
Number of Analysts
13
Last Close Price
139,50 $
Average target price
160,00 $
Spread / Average Target
14,7%
Please enable JavaScript in your browser's settings to use dynamic charts.